Category: Healthcare

A Historic Milestone in Gene Therapy The gene therapy landscape has reached a pivotal moment, marked by the FDA’s recent approval of two groundbreaking therapies for sickle cell disease (SCD)… Continue reading How is Gene Therapy Redefining the Current Healthcare Landscape?

The pharmaceutical landscape is poised for significant shifts as several blockbuster drugs approach their patent expiration dates. With patents on top-selling drugs such as Keytruda, Semaglutide, and Eliquis set to… Continue reading Strategic Opportunities for Generics: Capitalizing on Expiring Patents of Top-Selling Drugs

Introduction Neurocosmetics, a unique and innovative field that fuses neuroscience and skincare, is not just poised but ready to revolutionize the beauty industry. This blog delves into the current landscape… Continue reading Neurocosmetics: Transforming Beauty Through the Power of Neuroscience

Overview California’s recent legislative initiative, Assembly Bill 2491, is a significant step towards safeguarding young consumers from potentially harmful skincare products. This bill, effective January 1, 2025, aims to prohibit… Continue reading California Bill Proposes Ban on Anti-Aging Skincare for Kids Under 13

Overview According to Ingenious e-Brain, the cosmetic sector is amongst the most rapidly expanding industries globally and is projected to grow steadily at a compound annual growth rate (CAGR) of… Continue reading Sustainable Cosmetic Ingredients from Waste: A Crucial Approach

Overview 2024 seems to be a game-changing year for the healthcare industry as new techniques and innovative technologies integrated with Artificial Intelligence (AI) and Machine Learning (ML) are emerging rapidly.… Continue reading AI in Healthcare: Key Expectations for 2024

The world of advanced therapeutics medicinal products (ATMPs) particularly the cell and gene therapies (C&GT) space has been experiencing outstanding growth over the last few years, with a number of… Continue reading How is CAR-T Cell Therapy Evolving in Pharmaceutical Industry?

Overview Chimeric antigen receptor (CAR)-T cells are genetically engineered cells primarily known for targeting and treating liquid cancers, i.e., leukemia and lymphoma. The success rate in these hematological malignancies has… Continue reading Uncovering the Capabilities of CAR-T Cell Therapy in Cancer Treatment

Overview Substantial progress toward precision medicines and continued innovation across cancer diagnosis & treatment technologies have led to phenomenal spending on cancer care. The global expenditure on cancer medicine development… Continue reading Mapping trends for understanding oncology sector transformation

With the advent of personalized medicines, cancer treatment has been undergoing a radical transition in the therapeutic paradigm, shifting from location-specific (tissue/organ) to molecular-specific/ tumor-agnostic therapies. Tumor–agnostic treatment represents a… Continue reading Tumor-agnostic treatments: bold frontier in oncology drug dev.